The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126672261 12667226 1 I 20160805 20160819 20160819 EXP US-CIPLA LTD.-2016US17326 CIPLA BUTANI L, DUCORE J. END-STAGE RENAL DISEASE FROM CAST NEPHROPATHY IN A TEENAGER WITH NEUROENDOCRINE CARCINOMA. JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2016;38 (5):E177 TO E179 0.00 Y 0.00000 20160819 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126672261 12667226 1 PS Irinotecan IRINOTECAN 1 Unknown UNK U U 77219
126672261 12667226 2 SS Irinotecan IRINOTECAN 1 Unknown UNK, SECOND CYCLE U U 77219
126672261 12667226 3 SS CARBOPLATIN. CARBOPLATIN 1 Unknown UNK U U 0
126672261 12667226 4 SS CARBOPLATIN. CARBOPLATIN 1 Unknown UNK, SECOND CYCLE U U 0
126672261 12667226 5 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Unknown UNK U U 0
126672261 12667226 6 SS PACLITAXEL. PACLITAXEL 1 Unknown UNK U U 0
126672261 12667226 7 SS ETOPOSIDE. ETOPOSIDE 1 Unknown UNK U U 0
126672261 12667226 8 SS IFOSFAMIDE. IFOSFAMIDE 1 Unknown UNK U U 0
126672261 12667226 9 SS VINORELBINE VINORELBINEVINORELBINE TARTRATE 1 Unknown UNK U U 0
126672261 12667226 10 SS SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) SULFAMETHOXAZOLETRIMETHOPRIM 1 Unknown UNK, 3 TIMES A WEEK U 0
126672261 12667226 11 SS Penicillin PENICILLIN 1 Unknown UNK, QD U 0 QD
126672261 12667226 12 SS QIZHEN HERBALS 1 Unknown UNK U 0
126672261 12667226 13 C Acetaminophen-hydrocodone 2 Unknown UNK U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126672261 12667226 1 Neuroendocrine carcinoma metastatic
126672261 12667226 3 Neuroendocrine carcinoma metastatic
126672261 12667226 5 Neuroendocrine carcinoma metastatic
126672261 12667226 6 Neuroendocrine carcinoma metastatic
126672261 12667226 7 Neuroendocrine carcinoma metastatic
126672261 12667226 8 Neuroendocrine carcinoma metastatic
126672261 12667226 9 Neuroendocrine carcinoma metastatic
126672261 12667226 10 Prophylaxis
126672261 12667226 11 Prophylaxis
126672261 12667226 13 Abdominal discomfort

Outcome of event

Event ID CASEID OUTC COD
126672261 12667226 OT
126672261 12667226 DE
126672261 12667226 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126672261 12667226 Abdominal distension
126672261 12667226 Constipation
126672261 12667226 Death
126672261 12667226 Disease progression
126672261 12667226 End stage renal disease
126672261 12667226 Haemodialysis
126672261 12667226 Hypersplenism
126672261 12667226 Myeloma cast nephropathy
126672261 12667226 Renal tubular necrosis
126672261 12667226 Thrombocytopenia
126672261 12667226 Treatment failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found